ArticlePulmonary therapy2026

Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling Study.

Benjamin Yarnoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.